Product-Focused Webinar | Personalized Integrative Oncology: State of the Science by Dr Michael Traub, ND, DHANP, FABNO
This is the non-CE part of the webinar ‘Personalized Integrative Oncology: State of Science by Dr Michael Traub, ND, DHANP, FABNO that focuses on Cardiovascular Health, and discusses key products focused on Integrative Oncology. Dr. Michael Traub, DHANP, FABNO Dr. Traub received a B.S. from the University of California, Irvine in 1976, graduated from NCNM […]
Personalized Integrative Oncology: State of the Science by Dr Michael Traub, ND, DHANP, FABNO
Patient use of integrative oncology (the inclusion of nonconventional treatments alongside the conventional standard of care) continues to grow, with some studies showing its use in cancer patients to be as high as 91%. Naturopathic physicians are primary care providers who use integrative therapies to deliver patient-centred care. The Oncology Association of Naturopathic Physicians (OncANP) […]
Small Intestinal Bacterial Overgrowth and Rosacea: The Gut-Skin Connection by Dr Michael Traub, ND, DHANP, FABNO
Increasing evidence suggests that the gut-skin axis is implicated in the pathogenesis of rosacea. Sufficient data exists to support the concept that the gut microbiome plays a role in the inflammatory cutaneous response and there appears to be associations with small intestinal bacterial overgrowth and Helicobacter pylori infection. A dysbiotic microbiome and an innate immune system dysregulation […]
Small Intestinal Fungal Overgrowth (SIFO): what is the evidence? by Dr Michael Traub, ND, DHANP, FABNO
Published data based on duodenal aspirated juice in patients with persistent unexplained GI symptoms has shown that 25% have exclusive small intestinal fungal overgrowth (SIFO), 30% have exclusive SIBO, and 45% have mixed SIBO and SIFO. Stool tests are not an accurate test for SIFO due to the fact that there is an abundance of […]
Small Intestinal Fungal Overgrowth (SIFO): what is the evidence? by Dr Michael Traub, ND, DHANP, FABNO
Published data based on duodenal aspirated juice in patients with persistent unexplained GI symptoms has shown that 25% have exclusive small intestinal fungal overgrowth (SIFO), 30% have exclusive SIBO, and 45% have mixed SIBO and SIFO. Stool tests are not an accurate test for SIFO due to the fact that there is an abundance of […]
Small Intestinal Bacterial Overgrowth (SIBO) – An Update, by Dr Michael Traub, ND, DHANP, CCH, FABNO
Small intestinal bacterial overgrowth (SIBO) is a common disorder, yet poorly recognized even within the conventional gastroenterology community. There is growing awareness of SIBO in North America since the 2006 publication of Pimentel’s book “A New IBS Solution: Bacteria – The Missing Link in Treating Irritable Bowel Syndrome.” SIBO tends to recur after initial treatment […]
Integrative Approach to Actinic Keratosis and Non-melanoma Skin Cancer, Dr Michael Traub, ND, DHANP, CCH, FABNO
Actinic keratosis (AK) is a cutaneous lesion that results from the proliferation of atypical epidermal keratinocytes. AKs represent early lesions on a continuum with squamous cell carcinoma (SCC) and occasionally progress to SCC. AKs often present as erythematous and scaly macules or papules; lesions are most commonly detected in adults with fair skin. Chronic sun […]
Integrative Approach to Melanoma, by Dr Michael Traub, ND, DHANP, CCH, FABNO
Dr Traub was recognized for his many years of service to the American Association of Naturopathic Physicians, including President from 2001-2003, when he was honored with the 2006 Physician of the Year Award. His father was a dermatologist, and this inspired Dr Traub to undertake extra study in this subject. He has taught dermatology at […]
Integrative Approach to Psoriasis, by Dr Michael Traub, ND, DHANP, CCH, FABNO
Psoriasis is a severe, common, multifaceted chronic immune-mediated systemic inflammatory disease resulting from genetic, epigenetic, environmental, and lifestyle factors. Inflammation driven by tumor necrosis factor-α/interleukin-23/interleukin-17 axis is now known to be the major mechanism in the development of psoriasis. In addition, psoriasis has an autoimmune nature that manifests as autoreactive T cells and is co-morbid […]
Integrative Approach to Atopic Dermatitis, by Dr Michael Traub, ND, DHANP, CCH, FABNO
Atopic dermatitis (AD) is one of the most common inflammatory skin diseases. It usually presents in childhood and may persist into adult years, and less frequently develops in midlife. It is characterized by recurrent pruritic, localized eczema, often with environmental fluctuations. Many patients have food allergies and other atopic disorders such as asthma and allergic rhinitis. The prevalence of AD […]
